Filters








3 Hits in 11.1 sec

2DB: a Proteomics database for storage, analysis, presentation, and retrieval of information from mass spectrometric experiments

Jens Allmer, Sebastian Kuhlgert, Michael Hippler
2008 BMC Bioinformatics  
The amount of information stemming from proteomics experiments involving (multi dimensional) separation techniques, mass spectrometric analysis, and computational analysis is ever-increasing.  ...  Conclusion: We present a proteomics database which aims to greatly reduce evaluation time of results from mass spectrometric experiments and enhance result quality by allowing consistent data handling.  ...  Acknowledgements We would like to thank Simon Mumford who edited the final version of this publication and Rainer Perske who promptly fixed all problems in our database and web development environment.  ... 
doi:10.1186/1471-2105-9-302 pmid:18605993 pmcid:PMC2475538 fatcat:s6evcr4omjburoweqxv5bvbarm

Label-free quantitation, an extension to 2DB

Jens Allmer
2009 Amino Acids  
We recently designed the 2DB database which aids storage, analysis, and publication of data from mass spectrometric experiments to identify proteins.  ...  Here an extension to the database application, named MSMAG, is presented which allows for more detailed analysis of the distribution of peptides and their associated proteins over the fractions of an experiment  ...  I am thankful to Ole Schulz-Trieglaff for providing the underlying datasets from their paper and additional clarifying information.  ... 
doi:10.1007/s00726-009-0317-9 pmid:19575279 fatcat:73xwfit4y5gtnnndenrga6732u

Abstracts from the Ninth Annual Meeting of the Society for Neuro-Oncology

2004 Neuro-Oncology  
Protein peaks that are differentially expressed are readily isolated for mass spectrometric identification using this system.  ...  A MECHANISM-BASED MODEL OF THE GENESIS OF BENIGN, ATYPICAL, AND MALIGNANT MENINGIOMAS GE-07. DIAGNOSTIC POTENTIAL OF PROTEOMIC ANALYSIS OF CEREBROSPINAL FLUID (CSF) FROM GLIOMA PATIENTS F.W.  ...  TMZ was administered at a dose of 150 mg/m 2 daily for 5 days for the first 4 weeks and then, if tolerated, at a dose of 200 mg/m 2 daily for 5 days every 4 weeks.  ... 
doi:10.1215/s1152851704100148 fatcat:iphxxorg6bgpdpuc7aba6fftb4